Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
C7 Advisors is a private investment and advisory firm focused on long-short investing in U.S. equities, with particular expertise in healthcare and technology. The firm appears to operate both as a money management platform and as a healthcare-focused advisory business rather than as a drug developer, biotech operator, or commercial healthcare services company. Publicly available materials indicate the business was founded in 2014 by Geoffrey Harris and markets sector-specialist investing capabilities, especially in healthcare. C7 Advisors is associated with the C7 Long-Short Fund and presents itself as a capital allocation and advisory organization, not a therapeutics pipeline company. For biotech analysts, the relevant takeaway is that C7 Advisors is healthcare-adjacent through investing and advisory work, rather than a life sciences company with proprietary R&D assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on C7 Advisors.